Medical Exercise Inc.
MDXR· OTC
Filed Feb 13, 2026 · 10-Q · 44 days after period end · 0001213900-26-016247
| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | — | $0.00 |
| Net Income | -$25.82K | -$141.21K |
| EPS Diluted | — | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medical Exercise Inc. · CIK 2001249 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Feb 13, 2026 · 44 d after period end